ENOXABARA® Enoxaparin 60 mg | Libya
Advanced solution designed to reduce the risk of thrombosis and improve patient safety.
ENOXABARA® Enoxaparin 60 mg Injection | BAYADERCARE Libya
Balanced anticoagulation is essential in patients requiring both preventive and therapeutic management of thromboembolic conditions. LMWH therapies provide reliable and controlled anticoagulant activity across hospital and clinical settings in Libya.
|
| ENOXABARA® 60 mg is designed for both prevention and treatment of thromboembolic disorders, providing controlled inhibition of factor Xa activity. |
| Specifications: |
| 60 mg / 0.6 ml |
| Injection |
| Uses: |
| DVT prevention & treatment |
| VTE management |
| Hospital anticoagulation |
FAQ
Is ENOXABARA 60 mg available in Libya?
Yes, it is available through BAYADERCARE across Libya.
What is it used for?
| Prevention and treatment of thrombosis |
Enoxabara Enoxaparin 40 mg Injection
Enoxabara Enoxaparin 40 mg Anti-Xa injection for anticoagulant support and thrombosis prevention in Libya.